SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-051791
Filing Date
2010-10-22
Accepted
2010-10-22 17:08:58
Documents
2
Period of Report
2010-10-21

Document Format Files

Seq Description Document Type Size
1 rrd288196.html 3  
1 rrd288196.xml 3 8709
2 LIMITED POWER OF ATTORNEY rrd258388_292382.htm EX-24.1 3899
  Complete submission text file 0001181431-10-051791.txt   14605
Mailing Address C/O AEGERION PHARMACEUTICALS, INC. CENTERPOINTE IV, 1140 ROUTE 22 EAST BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 101137856

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations